Tuesday, July 3, 2012

Low Testosterone Levels Can Improve With Weight Loss, Exercise

Researchers evaluated 891 middle-aged men with impaired glucose tolerance and low testosterone levels who undertook a 1-year lifestyle modification program involving 150 minutes per week of exercise and calorie and fat reductions in their diets.

Participants had a nearly 50% increase in testosterone levels, researchers announced.

Although noting that the study reinforces existing knowledge of the effect obesity has on blood testosterone levels, and that reversing the excesses weight improves the effect, Dr. Handelsman cautioned that the remedy is not testosterone treatment.

"It is important to state clearly that the lower blood testosterone levels are not a true deficiency state; rather, they are a barometer of ill health, as opposed to a real deficiency state," he told Medscape Medical News.
"An important implication is that such men should not be treated with testosterone."

Read the full Medscape Medical News report here
(May require free sign-up)


Is Quality of Life Better With Active Surveillance?

Way too many men who are undergoing radical prostatectomy are being told, "Well, you may have a little trouble with some sexual function." They are given the impression that there is a high chance that functioning will return to normal, and they may underestimate their risk for problems in both urinary and sexual functioning.

We need to provide better counseling for men who are going to have these therapies so they understand the potential tradeoffs of surgery or seed implantation. For surgery, outcomes are not as good as patients have been led to believe in the past. This is going to depend on many factors, such as the patient population, and maybe most important, on the surgeon who is providing the treatment.

Read the full commentary from Dr. G. Chodak here
(May require free sign up)

Friday, June 1, 2012

The Issue of 'Overdiagnosis'

I have just read an interesting article on the subject of 'overdiagnosis' which is of special relevance at this time when we find ourselves in the midst of the controversy regarding screening for prostate cancer.

The NHS Choices article reviews a 'Daily Mail' (U.K.) newspaper report about a British Medical Journal article, the authors of which say that there is increasing evidence that too many people are being overdosed, overtreated and overdiagnosed.

Ths NHS article gives an excellent explanation of the term 'overdiagnosis' and gives examples relating to such conditions as breast and thyroid cancers, chronic kidney disase, asthma, osteoporosis, high cholesterol and, of course, prostate cancer.

Click here for the full NHS Choices article

Wednesday, May 30, 2012

Prostate Cancer Screening - the Debate Continues

As we have already reported in this recent post, there has already been some professional criticism of the US Preventive Services Task Force Policy advising against routine prostate cancer screening.

It was with interest that I read two commentaries from prostate cancer expert Dr. Gerald Chodak which address some of these criticisms.

The first point Dr. Chodak makes is that the criticism is almost exclusively focussed on the men who MIGHT miss out on 'potentially curative therapy' and ignores all those men who are actually being harmed by screening and treatment.

On his website ProstateVideos.com, Dr. Chodak has created a checklist of facts about prostate cancer in the form of a prostate cancer screening consent form which can help to put the current 'debate' into perspective and is well worth reading.

In his second commentary, Dr. Chodak refers to and recommends the following CNN article written by psychologist Dr. Charles Raison who talks about the mental health side of PSA screening:
The Danger of Fearing Cancer


Sunday, May 27, 2012

Review of the Effectiveness of Saw Palmetto for treating BPH

Saw Palmetto is a herbal remedy used by many men to treat the symptoms of benign prostatic hyperplasia (enlarged prostate).

Although early studies on the use of Saw Palmetto confirmed that symptoms of BPH such as difficulty urinating, dripping and frequent urination at night were all eased using the remedy, a review of 17 more recent studies (which used more reliable testing methods) show that Saw Palmetto was no better at alleviating these symptoms than placebo.

The leader of one of the most recent of the studies, Dr. Michael Barry, agreed that taking Saw Palmetto definitely did make a difference to the symptoms but the improvement was seen equally in those men in the trial who took only the placebo.

Dr. Barry said that some men may still want to try Saw Palmetto as just the expectation of feeling better will yield some improvement.

For details of the research and the treatment of BPH, read the full Reuters Health Report.

Saturday, May 26, 2012

Analysing the Cost of Avoiding Prostate Cancer Screening

Following finalization of the US Preventive Services Task Force Policy for prostate cancer screening which recommended against such screening, Dr. E. David Crawford & colleagues suggest that this approach may ultimately cost more due to having to treat greater number of patients with advanced disease.


Whilst adopting the USPSTF recommendation would initially save in the vicinity of $2.4 billion, the cost of treating men who will subsequently be diagnosed with 'clinically significant' prostate cancer would far exceed $2.4 billion.

Dr. Crawford also expressed concern that lack of screening would result in missing 0.57% to 1.22% of significant prostate cancer cases.

Dr. Crawford recommended that urologists should read the USPSTF report and give consideration to suggestions such as extending the amount of time in between screening individuals, using a better marker of disease progression and separating diagnosis from treatment.

Chicago urologist Anthony J. Schaeffer pointed out that it must be remembered that diagnosis does not necessarily have to lead to treatment and also that the ultimate decision as to whether or not to have a PSA test must be left to the patient, with his doctor providing him with sufficient knowledge to make such a decision.

Read the full report at Medscape Medical News (free sign-up may be required).

Thursday, May 24, 2012

Dr. Chodak on routine prostate cancer screening


As a follow-up to our story on the U.S. Preventive Services Task Force recommendation against routine prostate cancer screening, here's leading urologist and prostate cancer specialist Dr. Gerald Chodak's video review of the recommendation:



In this video Dr. Chodak explains that the reason for the recommendation is fundamentally that, according the best information currently available, the benefit of routine screening is very small (or non-existent) and is outweighed by the harms of such screening.

Dr. Chodak points out that a PSA blood test itself does not cause undue pain, discomfort or suffering but that an abnormal test result means that one or more prostate biopsies will be called for and such biopsies are not without side-effects.

If prostate cancer is actually diagnosed, the treatments also all have side-effects which can include sexual dysfunction, loss of bladder control and other complications.

The bottom line is that, if diagnosed, the chances of suffering treatment side-effects are much greater than the chances of being able to avoid suffering and/or death from prostate cancer.

Dr. Chodak refers to a recent study which showed that there was no difference in survival after 10 years in men whose prostate cancer was treated or left untreated.